Johnson & Johnson alleged that several drug distributors and pharmacies are selling counterfeit versions of its HIV drugs, in the latest lawsuit a large pharmaceutical company has filed to combat illicit sales of drugs in the U.S.
J&J said in a suit made public on Tuesday that the drugs it alleged were counterfeit presented an acute threat to public health. In some cases, the company said, bottles labeled as one drug were filled with pills of a different HIV medicine. In at least one instance, a bottle purporting to be HIV medication contained antipsychotic pills used to treat conditions including schizophrenia and bipolar disorder, J&J said in court documents. The lawsuit, filed in U.S. District Court for the Eastern District of New York, makes claims including federal trademark infringement.
To Read the Full Story
